These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11375345)

  • 1. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals.
    Boeri D; Maiello M; Lorenzi M
    Diabetes; 2001 Jun; 50(6):1432-9. PubMed ID: 11375345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
    Li W; Yanoff M; Liu X; Ye X
    Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I mRNA and signaling in the diabetic retina.
    Gerhardinger C; McClure KD; Romeo G; Podestà F; Lorenzi M
    Diabetes; 2001 Jan; 50(1):175-83. PubMed ID: 11147784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro.
    Podestà F; Romeo G; Liu WH; Krajewski S; Reed JC; Gerhardinger C; Lorenzi M
    Am J Pathol; 2000 Mar; 156(3):1025-32. PubMed ID: 10702418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
    Kanwar M; Chan PS; Kern TS; Kowluru RA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.
    Mizutani M; Kern TS; Lorenzi M
    J Clin Invest; 1996 Jun; 97(12):2883-90. PubMed ID: 8675702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide and retinal microangiopathy in diabetes.
    Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
    Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
    Mathews MK; Merges C; McLeod DS; Lutty GA
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of reduced Connexin 43 expression with retinal vascular lesions in human diabetic retinopathy.
    Tien T; Muto T; Zhang J; Sohn EH; Mullins RF; Roy S
    Exp Eye Res; 2016 May; 146():103-106. PubMed ID: 26738943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
    Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.
    Zhang J; Gerhardinger C; Lorenzi M
    Diabetes; 2002 Dec; 51(12):3499-504. PubMed ID: 12453906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Diabetic Macular Nonperfusion With Outer Retinal Disruption on Optical Coherence Tomography.
    Scarinci F; Jampol LM; Linsenmeier RA; Fawzi AA
    JAMA Ophthalmol; 2015 Sep; 133(9):1036-44. PubMed ID: 26158562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericytes and the pathogenesis of diabetic retinopathy.
    Hammes HP; Lin J; Renner O; Shani M; Lundqvist A; Betsholtz C; Brownlee M; Deutsch U
    Diabetes; 2002 Oct; 51(10):3107-12. PubMed ID: 12351455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.
    Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging increases retinal vascular lesions characteristic of early diabetic retinopathy.
    Roy S; Tonkiss J; Roy S
    Biogerontology; 2010 Aug; 11(4):447-55. PubMed ID: 20119717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular wall von Willebrand factor in human diabetic retinopathy.
    Boeri D; Cagliero E; Podestá F; Lorenzi M
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):600-7. PubMed ID: 8113010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Müller cell changes in human diabetic retinopathy.
    Mizutani M; Gerhardinger C; Lorenzi M
    Diabetes; 1998 Mar; 47(3):445-9. PubMed ID: 9519752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous flare and retinal capillary changes in eyes with diabetic retinopathy.
    Nguyen NX; Schönherr U; Küchle M
    Ophthalmologica; 1995; 209(3):145-8. PubMed ID: 7630621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.
    Stitt A; Gardiner TA; Alderson NL; Canning P; Frizzell N; Duffy N; Boyle C; Januszewski AS; Chachich M; Baynes JW; Thorpe SR
    Diabetes; 2002 Sep; 51(9):2826-32. PubMed ID: 12196477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.